Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 039025/0935 | |
| Pages: | 5 |
| | Recorded: | 06/28/2016 | | |
| Attorney Dkt #: | PAT034579-US-PCTD02 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
15187872
|
Filing Dt:
|
06/21/2016
|
|
Publication #:
|
|
Pub Dt:
|
11/10/2016
| | | | |
|
Title:
|
COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL]-METHYL}-VALINE AND (2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER MOIETIES AND CATIONS
|
|
|
Assignee
|
|
|
|
|
| ONE HEALTH PLAZA |
| EAST HANOVER, NEW JERSEY 07936 |
|
|
Correspondence name and address
|
| |
DAVID KURLANDSKY
|
| |
NOVARTIS PHARMACEUTICALS CORPORATION
|
| |
ONE HEALTH PLAZA, BLDG 101
|
| |
EAST HANOVER, NJ 07936
|
Search Results as of:
06/14/2024 02:52 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
